The test for the diagnosis of IgG antibody response after SARS-CoV-2 infection and/or vaccination, i.e. allows monitoring of the level of protection and neutralizing antibodies.
    Product Code: ODZ-497/5ST
Call for price
Ask a question about this product at orders@vidia.cz


ELISA-VIDITEST anti-SARS-CoV-2 (RBD) IgG quantum - ELISA kit for qualitative, semi-quantitative and quantitative detection of IgG antibody against RBD (receptor binding domain) of SARS-CoV-2 coronavirus protein in human serum and plasma. The RBD protein is part of the surface spike protein (S1 portion), which has a virus that specifically binds to the ACE 2 (angiotensin-converting enzyme 2) receptor of the host cell during infection. If different users are present in the body (after vaccination of vaccines from different manufacturers and / or after production of infection), they can be used on the RBD domains of the virus.

Accurate test for the detection of antibodies using ELISA principles available to all laboratory service providers.

Based on the study, the sensitivity was found to be 94% and the specificity of the test 97%.


Test type: Solid phase immunochromatographic test

Type of determination: IgG type antibodies

Rating type: Quantitative / Semiquantitative / Qualitative

Sample type: Serum / Plasma isolated from venous or capillary blood

Kit contents: The kit contains a 96-wells